ID
16792
Description
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine; ODM derived from: https://clinicaltrials.gov/show/NCT00518427
Link
https://clinicaltrials.gov/show/NCT00518427
Keywords
Versions (1)
- 8/7/16 8/7/16 -
Uploaded on
August 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Type 2 NCT00518427
Eligibility Diabetes Type 2 NCT00518427
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Autoimmune diabetes
Data type
boolean
Alias
- UMLS CUI [1]
- C0205734
Description
Thiazolidinedione
Data type
boolean
Alias
- UMLS CUI [1]
- C1257987
Description
Retinopathy with surgical treatment
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0011884
- UMLS CUI [1,2]
- C0543467
Description
Drug abuse
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
hypersensitivity to insulin glagine excipients
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0907402
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Diabetes Type 2 NCT00518427
- StudyEvent: Eligibility
C0860160 (UMLS CUI [2,1])
C0021658 (UMLS CUI [2,2])
C0860160 (UMLS CUI [3,1])
C0359086 (UMLS CUI [3,2])
C0178602 (UMLS CUI [1,2])
C0017642 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0061323 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0025598 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0050393 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0281588 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,2])
C0907402 (UMLS CUI [1,2])